This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Innovations of Fengsheng Li in Immunotherapy
Introduction
Fengsheng Li is a notable inventor based in Scarsdale, NY (US). He has made significant contributions to the field of immunotherapy, particularly through his work on PD-1 binding proteins. His innovative approach aims to enhance host immunity, providing potential treatments for infections and cancer.
Latest Patents
Fengsheng Li holds a patent for PD-1 binding proteins. This invention features a subset of binding proteins that inhibit the interaction between PD-L1 and the PD-1 receptor. By modulating the PD-1 signaling pathway, these proteins can effectively enhance the immune response, offering new avenues for therapeutic interventions.
Career Highlights
Fengsheng Li is associated with Merck Sharp & Dohme Corp., a leading pharmaceutical company. His work there has focused on developing novel strategies to manipulate immune responses, which is crucial in the fight against various diseases.
Collaborations
Fengsheng Li has collaborated with esteemed colleagues, including Danilo R Casimiro and Tong-Ming Fu. These partnerships have fostered a collaborative environment that enhances the research and development of innovative therapies.
Conclusion
Fengsheng Li's contributions to immunotherapy through his patent on PD-1 binding proteins exemplify the impact of innovative research in medicine. His work continues to pave the way for advancements in treating infections and cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile